144 related articles for article (PubMed ID: 25405645)
1. Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cells.
Kasukabe T; Okabe-Kado J; Kato N; Honma Y; Kumakura S
Int J Oncol; 2015 Feb; 46(2):841-8. PubMed ID: 25405645
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of rapamycin-induced Akt phosphorylation by cotylenin A correlates with their synergistic growth inhibition of cancer cells.
Kasukabe T; Okabe-Kado J; Haranosono Y; Kato N; Honma Y
Int J Oncol; 2013 Feb; 42(2):767-75. PubMed ID: 23255002
[TBL] [Abstract][Full Text] [Related]
3. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
[TBL] [Abstract][Full Text] [Related]
4. Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2.
Kasukabe T; Okabe-Kado J; Honma Y
Cancer Sci; 2008 Aug; 99(8):1693-8. PubMed ID: 18754885
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.
Zhang S; Ma C; Pang H; Zeng F; Cheng L; Fang B; Ma J; Shi Y; Hong H; Chen J; Wang Z; Xia J
Biochem Biophys Res Commun; 2016 Jan; 469(1):55-61. PubMed ID: 26592661
[TBL] [Abstract][Full Text] [Related]
6. Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer.
Nooshinfar E; Bashash D; Safaroghli-Azar A; Bayati S; Rezaei-Tavirani M; Ghaffari SH; Akbari ME
Biomed Pharmacother; 2016 Oct; 83():456-465. PubMed ID: 27427852
[TBL] [Abstract][Full Text] [Related]
7. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
[TBL] [Abstract][Full Text] [Related]
9. Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts.
Kasukabe T; Okabe-Kado J; Kato N; Sassa T; Honma Y
Breast Cancer Res; 2005; 7(6):R1097-110. PubMed ID: 16457690
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
11. The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude mice.
Yu R; Wang D; Ren X; Zeng L; Liu Y
Leuk Res; 2014 Sep; 38(9):1085-90. PubMed ID: 24908354
[TBL] [Abstract][Full Text] [Related]
12. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
[TBL] [Abstract][Full Text] [Related]
13. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
14. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
Wang Y; An R; Dong X; Pan S; Duan G; Sun X
Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
[TBL] [Abstract][Full Text] [Related]
17. Synergistic combination therapy with cotylenin A and vincristine in multiple myeloma models.
Takahashi T; Honma Y; Miyake T; Adachi K; Takami S; Okada M; Kumanomidou S; Ikejiri F; Jo Y; Onishi C; Kawakami K; Moriyama I; Inoue M; Tanaka J; Suzumiya J
Int J Oncol; 2015 Apr; 46(4):1801-9. PubMed ID: 25672400
[TBL] [Abstract][Full Text] [Related]
18. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
[TBL] [Abstract][Full Text] [Related]
19. Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.
Hassani S; Ghaffari SH; Zaker F; Mirzaee R; Mardani H; Bashash D; Zekri A; Yousefi M; Zaghal A; Alimoghaddam K; Ghavamzadeh A
Ann Hematol; 2013 Sep; 92(9):1207-20. PubMed ID: 23645216
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K2 and cotylenin A synergistically induce monocytic differentiation and growth arrest along with the suppression of c-MYC expression and induction of cyclin G2 expression in human leukemia HL-60 cells.
Maniwa Y; Kasukabe T; Kumakura S
Int J Oncol; 2015 Aug; 47(2):473-80. PubMed ID: 26046133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
